Palantir Technologies

Palantir Technologies specializes in big data analytics and artificial intelligence software platforms. While it does not develop drugs or biologic therapies, its platforms are widely used in the life sciences and healthcare sectors for data integration, research acceleration, population health management, clinical trial optimization, and public health initiatives. Major recent projects include supporting the NHS Federated Data Platform in the UK and partnering with The Joint Commission to enhance patient safety through AI-driven analytics[6][8][9][10]. Its software has been instrumental during COVID‑19 response efforts and continues to support precision medicine research[6][10].

The company’s core products—Foundry (commercial/healthcare), Gotham (defense/intelligence), Apollo (CI/CD orchestration), and AIP (AI platform)—are used by governments, corporations, hospitals, pharmaceutical companies, and academic researchers worldwide[1][4][5].

In healthcare specifically:

• Supported over 50 peer-reviewed publications in 2023 using Foundry for hospital operations research, oncology drug studies, learning modalities analysis etc.[10]
• Partnered with NHS England on a £330 million contract to build the Federated Data Platform—the largest single point of access to UK health data[8]
• Strategic partnership with The Joint Commission to apply AI/data analytics for accreditation/certification processes across global hospitals[9]
• Used by pharma companies like Merck KGaA for R&D data integration/analysis[1]

However—despite deep involvement as an enabling technology provider—Palantir itself does not discover/develop drugs or own therapeutic pipelines.